Blood test, lipase
Facility: Goodland Regional Medical Center
Billing Code: 83690 (CPT)
- CPT Billing Code: 83690
- Insurance Median: $61
- Cash Discount Price: $61
- vs. Medicare Baseline: 8.85x Medicare
Average discount available for prompt cash payment at this facility.
Median negotiated contract rate across all mapped commercial carriers.
Standard federal government reimbursement rate for this code.
Visual Cost Comparison vs. Medicare
Understanding this gauge: We use the federal Medicare rate of $6.89 as the cost baseline. Rates below the baseline represent excellent value. In-network commercial rates commonly hover around 150% - 250% of Medicare, while rates exceeding 300% are elevated. Hover over the green and blue markers to view detailed calculations.
Elevated Commercial Rate Alert (Value-Gap)
The negotiated rate at this facility is 885% of the Medicare baseline (a markup of 785%). Patients with high-deductible plans or out-of-network benefits may face excessive out-of-pocket costs.
Out-of-Pocket Cost Estimator
Estimate whether it is more economical to use your insurance or pay the upfront self-pay cash rate.
Commercial Insurance Negotiated Rates
Negotiated contract ranges established by major commercial carriers at this facility.
| Carrier / Plan Group | Contract Rate Range | vs. Medicare Reference |
|---|---|---|
| Blue Cross Blue Shield | $28 | 406% |
| Wppa | $58 - $61 | 842% |
| UnitedHealthcare | $61 | 885% |
Consumer Guidance & Cost Commentary
For the blood test for lipase (CPT 83690) at Goodland Regional Medical Center in Goodland, Kansas, the cash median price is $61.00, which is lower than the facility's gross charge of $68.00. While the facility is a Critical Access Hospital owned by the local government, patients should note that commercial insurance negotiated rates for this service range from $58.00 to $61.00 across three payers, including Blue Cross Blue Shield, Wppa, and UnitedHealthcare. Because the cash price is already below the negotiated rates paid by these insurers, paying out-of-pocket may not result in savings for those with high-deductible plans, as the insurance allowed amount often exceeds the cash price. However, if a patient has met their deductible or is paying out-of-pocket, the cash rate of $61.00 remains the most direct benchmark for self-pay.
When evaluating the cost relative to Medicare, the facility's cash rate of $61.00 is 8.9% higher than the Medicare amount of $6.89 for this procedure. It is important to understand that Medicare rates serve as a scientifically validated cost baseline, whereas commercial negotiated rates include administrative overhead and contract dynamics that can inflate the final price. Although the facility's cash rate is higher than the Medicare benchmark, patients should verify their specific plan's deductible status before assuming insurance will be cheaper. Additionally, since the facility is in-network for the listed payers, balance billing for this specific service is unlikely under federal protections, but patients should still request a prompt-pay discount if they choose to pay the cash rate directly to ensure they are receiving